Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Microglia in Health and Disease.
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis.
Cognitive-Motor Interference in Multiple Sclerosis: A Systematic Review of Evidence, Correlates, and Consequences.
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.
Understanding fatigue in paediatric multiple sclerosis: a systematic review of clinical and psychosocial factors.
Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).
[The usefulness of 3T magnetic resonance in the differential diagnosis of ischemic optic neuropathy and inflammatory optic neuritis].
[Guillain-Barré syndrome with dysphagia after frontal sinusitis.]
Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
Making myelin basic protein -from mRNA transport to localized translation.
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
Efficacy of gabapentin in the treatment of SUNCT syndrome.
Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.
[Semaphorin 4 in multiple sclerosis].
Role of Subventricular Zone Derived Neural Precursor Cells in the Therapy of Experimental Autoimmune Encephalomyelitis.
Therapeutic Cleavage of Anti-Aquaporin-4 Autoantibody in Neuromyelitis Optica by an Igg-Selective Proteinase.
The incidence and prevalence of neuromyelitis optica: a systematic review.
In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis.
Uric acid: a potential biomarker of multiple sclerosis and of its disability.
[Efficacy and safety of natalizumab in multiple sclerosis: data from the first five years of TOP (Tysabri Observational Program) study].
Detection of demyelination in multiple sclerosis by analysis of [Formula: see text] relaxation at 7 T.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
Caffeine treatment aggravates secondary degeneration after spinal cord injury.
Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study.
An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.

Pages